WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳NO PRODUCTS · NO PROTOCOLS · NO VENDORS✳WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳
← All Claim Checks
Source record · FDA labeling · reviewed July 16, 2026

Same ingredient name does not mean same FDA-approved product.

Misleading
The circulating claim

“If a vial says semaglutide, it is basically the same as Ozempic or Wegovy.”

What the source record says

FDA approval belongs to a specific drug product, formulation, manufacturer, and use. Trials of Wegovy, Ozempic, or Rybelsus do not establish the identity, sterility, strength, or performance of an unrelated vial sold under the ingredient name.

Why the claim misleads

A shared ingredient name is being used as proof that two products have the same manufacturing controls and clinical evidence.

Correction

Same ingredient name does not mean same FDA-approved product.

Primary sources
FDA-approved Wegovy labeling, 2026Open source ↗Semaglutide library entryOpen source ↗
What changed

Added the source-verified Claim Check to the structured claim/source/change registry.

What would change our answer

A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.

Version history · 1 entry
  1. v1 · 2026-07-16Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.